Seragon Pharmaceuticals
12780 El Camino Real, Suite #302
San Diego
California
92130
United States
Tel: 858-369-7600
Fax: 858-369-7650
Website: http://www.seragonpharm.com/
Email: info@Seragonpharm.com
9 articles with Seragon Pharmaceuticals
-
venBio Global Strategic Fund IV will invest primarily in drug companies focused on developing therapies for unmet medical needs.
-
Seragon Announces GenomeScore™, the First AI Platform to Measure Rate of Aging and Physiological Changes
8/4/2020
The novel algorithms combine epigenetic and transcriptome analyses to reveal how a person ages in different areas, and opens a door to personalized medicine in the future
-
Seragon Pharmaceuticals announces GenomeScore™, an AI platform to predict speed of aging and physiological changes
7/22/2020
Seragon Pharmaceuticals, Inc., a southern California biopharmaceutical company, announces GenomeScore™ platform, a neural network-trained algorithm combining epigenetic and transcriptome analysis to predict individuals' aging speed and assessing aspects of physiological functions.
-
Metracrine, based in San Diego, completed a Series C financing round worth $65 million.
-
Stealth SoCal Startup Metacrine Eyes $33 Million and Talent-Cash From Seragon Alums?
4/22/2015
-
Seragon Pharmaceuticals Announces Closing Of Its Acquisition By Genentech
8/28/2014
-
Genentech To Pay Up To $1.7 Billion For San Diego Biotech Firm Seragon Pharmaceuticals
7/7/2014
-
Seragon Pharmaceuticals Appoints Debasish Roychowdhury, M.D. To Its Clinical And Scientific Advisory Board And As Acting Chief Medical Officer
4/3/2014
-
Startup Seragon Pharmaceuticals Lands $30 Million in Series A Financing
10/16/2013